Basiliximab Chimeric Monoclonal Antibody
Basiliximabis a research-grade recombinant antibody targeting CD25. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
IL2-RA, IL-2R subunit alpha, TAC antigen, IL-2-RA, p55, IL2RA, IL-2 receptor subunit alpha, Interleukin-2 receptor subunit alpha, CD25
UniProt
P01589
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bik, Phosphorylated (Thr33) (Bcl-2 Interacting Killer, Apoptosis Inducer NBK, BP4, BIP1) (PE)
Bik, Phosphorylated (Thr33) (Bcl-2 Interacting Killer, Apoptosis Inducer NBK, BP4, BIP1) (PE)
USP7, CT (Ubiquitin Carboxyl-terminal Hydrolase 7, Ubiquitin Thioesterase 7, Ubiquitin-specific-processing Protease 7, Deubiquitinating Enzyme 7, Herpes virus-associated Ubiquitin-specific Protease, HAUSP) (Biotin) discontinued
